Cargando…
Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions
Environmental factors contribute to Type 1 diabetes (T1D) susceptibility. The gut microbiome, which includes bacteria, viruses, and fungi, contributes to this environmental influence, and can induce immunological changes. The gut viral component of the microbiome, related to T1D has mostly focused o...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863139/ https://www.ncbi.nlm.nih.gov/pubmed/31798584 http://dx.doi.org/10.3389/fimmu.2019.02654 |
_version_ | 1783471698695159808 |
---|---|
author | Pearson, James A. Tai, Ningwen Ekanayake-Alper, Dilrukshi K. Peng, Jian Hu, Youjia Hager, Karl Compton, Susan Wong, F. Susan Smith, Peter C. Wen, Li |
author_facet | Pearson, James A. Tai, Ningwen Ekanayake-Alper, Dilrukshi K. Peng, Jian Hu, Youjia Hager, Karl Compton, Susan Wong, F. Susan Smith, Peter C. Wen, Li |
author_sort | Pearson, James A. |
collection | PubMed |
description | Environmental factors contribute to Type 1 diabetes (T1D) susceptibility. The gut microbiome, which includes bacteria, viruses, and fungi, contributes to this environmental influence, and can induce immunological changes. The gut viral component of the microbiome, related to T1D has mostly focused on coxsackieviruses and rotavirus. The role of norovirus, another common enteric virus, in susceptibility to T1D was hitherto unknown. Norovirus is highly infectious and encountered by many children. We studied the mouse norovirus 4 (MNV4), related to human noroviruses, in the Non-obese diabetic (NOD) mouse model, to determine its role in influencing susceptibility to T1D. We infected MNV-free NOD mice with MNV4 by exposing the mice to MNV4-positive bedding from an endemically-infected mouse colony to mimic a natural infection. Control MNV-free NOD mice were exposed to MNV-free bedding from the same colony. Interestingly, MNV4 infection protected NOD mice from the development of T1D and was associated with an expansion of Tregs and reduced proinflammatory T cells. We also found MNV4 significantly modified the gut commensal bacteria composition, promoting increased α-diversity and Firmicutes/Bacteroidetes ratio. To elucidate whether T1D protection was directly related to MNV4, or indirectly through modulating gut microbiota, we colonized germ-free (GF) NOD mice with the MNV4-containing or non-MNV4-containing viral filtrate, isolated from filtered fecal material. We found that MNV4 induced significant changes in mucosal immunity, including altered Tuft cell markers, cytokine secretion, antiviral immune signaling markers, and the concentration of mucosal antibodies. Systemically, MNV4-infection altered the immune cells including B cell subsets, macrophages and T cells, and especially induced an increase in Treg number and function. Furthermore, in vitro primary exposure of the norovirus filtrate to naïve splenocytes identified significant increases in the proportion of activated and CTLA4-expressing Tregs. Our data provide novel knowledge that norovirus can protect NOD mice from T1D development by inducing the expansion of Tregs and reducing inflammatory T cells. Our study also highlights the importance of distinguishing the mucosal immunity mediated by bacteria from that by enteric viruses. |
format | Online Article Text |
id | pubmed-6863139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68631392019-12-03 Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions Pearson, James A. Tai, Ningwen Ekanayake-Alper, Dilrukshi K. Peng, Jian Hu, Youjia Hager, Karl Compton, Susan Wong, F. Susan Smith, Peter C. Wen, Li Front Immunol Immunology Environmental factors contribute to Type 1 diabetes (T1D) susceptibility. The gut microbiome, which includes bacteria, viruses, and fungi, contributes to this environmental influence, and can induce immunological changes. The gut viral component of the microbiome, related to T1D has mostly focused on coxsackieviruses and rotavirus. The role of norovirus, another common enteric virus, in susceptibility to T1D was hitherto unknown. Norovirus is highly infectious and encountered by many children. We studied the mouse norovirus 4 (MNV4), related to human noroviruses, in the Non-obese diabetic (NOD) mouse model, to determine its role in influencing susceptibility to T1D. We infected MNV-free NOD mice with MNV4 by exposing the mice to MNV4-positive bedding from an endemically-infected mouse colony to mimic a natural infection. Control MNV-free NOD mice were exposed to MNV-free bedding from the same colony. Interestingly, MNV4 infection protected NOD mice from the development of T1D and was associated with an expansion of Tregs and reduced proinflammatory T cells. We also found MNV4 significantly modified the gut commensal bacteria composition, promoting increased α-diversity and Firmicutes/Bacteroidetes ratio. To elucidate whether T1D protection was directly related to MNV4, or indirectly through modulating gut microbiota, we colonized germ-free (GF) NOD mice with the MNV4-containing or non-MNV4-containing viral filtrate, isolated from filtered fecal material. We found that MNV4 induced significant changes in mucosal immunity, including altered Tuft cell markers, cytokine secretion, antiviral immune signaling markers, and the concentration of mucosal antibodies. Systemically, MNV4-infection altered the immune cells including B cell subsets, macrophages and T cells, and especially induced an increase in Treg number and function. Furthermore, in vitro primary exposure of the norovirus filtrate to naïve splenocytes identified significant increases in the proportion of activated and CTLA4-expressing Tregs. Our data provide novel knowledge that norovirus can protect NOD mice from T1D development by inducing the expansion of Tregs and reducing inflammatory T cells. Our study also highlights the importance of distinguishing the mucosal immunity mediated by bacteria from that by enteric viruses. Frontiers Media S.A. 2019-11-12 /pmc/articles/PMC6863139/ /pubmed/31798584 http://dx.doi.org/10.3389/fimmu.2019.02654 Text en Copyright © 2019 Pearson, Tai, Ekanayake-Alper, Peng, Hu, Hager, Compton, Wong, Smith and Wen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Pearson, James A. Tai, Ningwen Ekanayake-Alper, Dilrukshi K. Peng, Jian Hu, Youjia Hager, Karl Compton, Susan Wong, F. Susan Smith, Peter C. Wen, Li Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions |
title | Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions |
title_full | Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions |
title_fullStr | Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions |
title_full_unstemmed | Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions |
title_short | Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions |
title_sort | norovirus changes susceptibility to type 1 diabetes by altering intestinal microbiota and immune cell functions |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863139/ https://www.ncbi.nlm.nih.gov/pubmed/31798584 http://dx.doi.org/10.3389/fimmu.2019.02654 |
work_keys_str_mv | AT pearsonjamesa noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT tainingwen noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT ekanayakealperdilrukshik noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT pengjian noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT huyoujia noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT hagerkarl noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT comptonsusan noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT wongfsusan noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT smithpeterc noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions AT wenli noroviruschangessusceptibilitytotype1diabetesbyalteringintestinalmicrobiotaandimmunecellfunctions |